Eurosurveillance最新文献

{"title":"Expression of concern for Euro Surveill. 2026;31(28).","authors":"","doi":"10.2807/1560-7917.ES.2026.31.36.260910ec","DOIUrl":"10.2807/1560-7917.ES.2026.31.36.260910ec","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 36","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13585422/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148943849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of a novel Shamonda <i>Orthobunyavirus</i> in dairy cattle, France, June 2026.","authors":"Mikail Kelleci, Maxime Fusade-Boyer, Delphine Chrétien, Elodie Durand, Mathias Mircovich, Aurélie Sécula, Benjamin Linard, Nicolas Herman, François Schelcher, Guillaume Croville, Stephan Zientara, Pierre Bessière, Jean-Luc Guérin","doi":"10.2807/1560-7917.ES.2026.31.33.2600689","DOIUrl":"10.2807/1560-7917.ES.2026.31.33.2600689","url":null,"abstract":"<p><p>In June 2026, acute fever, diarrhoea, lethargy and marked reduction of milk yield were reported in dairy cattle in eastern France. Unbiased Nanopore metagenomics on pooled plasma from affected cows detected Simbu serogroup <i>Orthobunyavirus,</i> provisionally named European Shamonda Virus, and recovered complete genomes. Segments L and M clustered with Nigerian Shamonda virus, whereas S showed a distinct clustering pattern, suggesting high mutation rate or reassortment. Similar findings in neighbouring countries indicate cross-border emergence requiring coordinated surveillance.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 33","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13498902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.","authors":"Liselotte Diaz Högberg, Vera Vlahović-Palčevski, Vivian H Leung","doi":"10.2807/1560-7917.ES.2026.31.34.2500976","DOIUrl":"10.2807/1560-7917.ES.2026.31.34.2500976","url":null,"abstract":"<p><p>BACKGROUNDEstablishing quantifiable targets for antimicrobial consumption (AMC) and stewardship activities can provide a structured framework for monitoring and evaluating progress in efforts to curb antimicrobial resistance (AMR).AIMWe aimed to map the presence and characteristics of national AMC-related targets in the human health domain across European Union (EU)/European Economic Area (EEA) countries, thereby creating an inventory to inform current and future target-setting initiatives.METHODSWe performed a survey within the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) to identify national AMC-related targets in force for 2025 or later.RESULTSBased on responses received from 25 EU/EEA countries, we identified a total of 67 nationally adopted AMC-related targets, active for 2025 or beyond, from 16 countries. Targets for population-level AMC indicators were the most frequently reported (73%), followed by patient-level AMC indicators (18%) and structural stewardship indicators (9%). The influential role of the 2023 EU Council Recommendation on AMR and its recommendations for national targets was particularly evident in our findings.CONCLUSIONThis inventory provides examples of national targets and related implementation and monitoring frameworks used across a range of settings and resource levels. Our findings highlight the importance of robust and sustainable surveillance infrastructure and reporting systems to support the development, implementation, monitoring and evaluation of AMC-related national targets. Such systems are also needed to enable targets that capture prescribing practices and antimicrobial stewardship activities, beyond overall consumption volume metrics alone.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 34","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13525357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148839744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A cohort study of persons exposed to highly pathogenic avian influenza A(H5N1) at premises with infected animals, England, 2023 to 2025.","authors":"Florence Halford, Paula B Blomquist, Neil Bray, Chloe Byers, Carmellie Inzoungou-Massanga, Carys Rees, Maria Waghorn, Motolani Awokoya, Rachel Lunt, Neil Cunningham, Michelle Chapman, Philippa Jones, Nicholas Machin, Georgios Chalikias, Alan Lord, Rachel Benee, Sophia Makki, Beatrix Kele, Andre Charlett, Katja Hoschler, Anika Singanayagam, Maria Zambon, Oluwakemi Olufon, Obaghe Edeghere, Meera Chand, Susan Hopkins, Deepti Kumar, Richard Puleston","doi":"10.2807/1560-7917.ES.2026.31.31.2500906","DOIUrl":"https://doi.org/10.2807/1560-7917.ES.2026.31.31.2500906","url":null,"abstract":"<p><p>BACKGROUNDThe ongoing panzootic of highly pathogenic avian influenza A(H5N1) presents a risk to human health both from infections resulting from exposure to infected birds or mammals, and from potential mutations enabling human-to-human transmission of a virus to which there is little or no population immunity.AIMThis cohort study was designed with the aim of informing assessments of the risk of avian influenza to human health and the public health management of influenza A(H5N1) exposures.METHODSWe recruited 428 individuals at 34 highly pathogenic avian influenza A(H5N1) outbreak sites between April 2023 to March 2025, throughout England. Through nasopharyngeal samples and questionnaires, we investigated risk factors including exposure periods and usage of personal protective equipment (PPE), and characteristics of influenza A(H5N1) infection.RESULTSThe median participant age was 37 years (interquartile range: 28-51 years), 296 (69%) were male. Most participants (85%) reported full PPE use when exposed, and 82 (19%) were vaccinated against seasonal influenza. Six persons tested PCR-positive for influenza A(H5N1), of whom three (< 1%) met the case definition for infection (two confirmed, one unclear) attributable to exposure periods. No severe illness was reported; no secondary cases were identified. None of the six cases with positive detections were vaccinated against seasonal influenza; two of them reported not wearing full PPE when exposed.CONCLUSIONWe recommend continued conscientious PPE use and the resumption of enhanced surveillance following detection of an increased risk of animal-human transmission, with a One Health focus, to mitigate pandemic risk of influenza A(H5N1).</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 31","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148683870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Whooping cough hospitalisations among patients with chronic conditions: a retrospective analysis of incidence and costs, France, 2008 to 2020.","authors":"Juan C Vargas-Zambrano, Mickael Arnaud, Ana Antunes, Khalil Karzazi, Johanna Despres, Regis Verdier, Florence Boisnard, Jerome Jund, Cecile Janssen, Didier Pinquier, Denis Macina","doi":"10.2807/1560-7917.ES.2026.31.32.2500561","DOIUrl":"https://doi.org/10.2807/1560-7917.ES.2026.31.32.2500561","url":null,"abstract":"<p><p>BACKGROUNDIn European countries, including France, the incidence and costs of whooping cough in people with chronic conditions remains understudied.AIMWe aimed to estimate cumulative incidence and costs of whooping cough hospitalisations in children, adolescents and adults with chronic conditions in France.METHODSWe extracted data from patients hospitalised with whooping cough with or without underlying chronic conditions, asthma, chronic obstructive pulmonary disease (COPD), diabetes and immunocompromising conditions between 2008 and 2020 using the Système National des Données de Santé (SNDS).RESULTSAmong the 10,893 patients hospitalised with whooping cough in 2008-2020, asthma and/or COPD were the most common chronic conditions. Of the 7,212 children and adolescents hospitalised, 1,263 (17.5%) had asthma and 68 (0.9%) had an immunocompromising condition. Of the 3,681 adults, 2,297 (62.4%) had asthma and/or COPD, 594 (16.1%) had an immunocompromising condition and 454 (12.3%) had diabetes. In children and adolescents, the highest cumulative incidence ratio (CIR) was among patients with an immunocompromising condition (adjusted CIR = 3.6; 95% confidence interval (CI): 2.8-4.6) whereas in adults, patients with asthma and/or COPD had the highest adjusted CIR (18.6; 95% CI: 17.4-19.9). Median hospitalisation costs were the highest for patients with an immunocompromising condition (EUR 4,401). No significant changes in healthcare resource utilisation were observed before and after whooping cough hospitalisation in adults.CONCLUSIONChronic conditions are associated with higher cumulative incidence of whooping cough-related hospitalisation in France. This highlights the importance of reducing whooping cough circulation, through strengthening vaccination programmes, particularly for those with chronic conditions.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 32","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13476727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148763844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An imported case of Bundibugyo virus infection, France, June 2026.","authors":"Morgane Mailhe, Delphine Pannetier, Estelle Yamani, Lyderic Aubert, Arnaud Tarantola","doi":"10.2807/1560-7917.ES.2026.31.31.2600627","DOIUrl":"10.2807/1560-7917.ES.2026.31.31.2600627","url":null,"abstract":"<p><p>In June 2026, an intensive care physician deployed in the Democratic Republic of the Congo and previously vaccinated against Ebola virus developed fatigue, nausea and headaches while returning to France. Bundibugyo virus was identified with RT-PCR. The patient was treated with remdesivir and recovered fully. Contact tracing identified five low-risk contacts and no secondary cases. Stringent infection prevention and control measures and multidisciplinary collaboration are important when managing suspected or confirmed Ebola disease cases, even with low viral loads.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 31","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13451861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148683868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Authors' response: Autochthonous transmission patterns of dengue virus serotype 2 in Italy: evidence from outbreaks in 2024.","authors":"Carla Molina Grané, Martina Del Manso, Patrizio Pezzotti, Stefano Merler, Piero Poletti","doi":"10.2807/1560-7917.ES.2026.31.34.2600721","DOIUrl":"10.2807/1560-7917.ES.2026.31.34.2600721","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 34","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13525356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148839753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Strengthening mosquito control to manage emerging mosquito-borne diseases.","authors":"Olivier Jt Briët, Antero Airaksinen, Laura Gillini, Maria Daniel Loureiro, Jeanne Vuaille, Vincent Delvaux, Ana Margarida Alho, Áine Collins, Céline M Gossner","doi":"10.2807/1560-7917.ES.2026.31.33.2600306","DOIUrl":"10.2807/1560-7917.ES.2026.31.33.2600306","url":null,"abstract":"<p><p>Mosquito-borne diseases such as dengue, chikungunya and West Nile virus infection become increasingly frequent in Europe. These developments require preparedness and coordinated response mechanisms across countries and sectors. Vector control is a central component of public health response, both for containing outbreaks and for reducing the risk of disease emergence. While mosquito control is important, evidence on the cost-effectiveness of most methods remains limited, complicating the design of evidence-based vector management strategies. In addition, the range of authorised vector control products is narrow and increasingly compromised by insecticide resistance. Mosquito control in European countries involves a diverse set of actors, and work on mosquito-borne diseases at European Union level spans several institutions with complementary mandates. Europe should therefore promote cross-sectoral collaboration through a One Health approach that brings together public health, environmental health, veterinary health and urban planning sectors, while engaging communities in mosquito surveillance and control. Continued investment in research to assess the cost-effectiveness, safety and ecological impact of existing and new vector control methods is needed to develop sustainable, science-based, integrated mosquito control strategies that protect public health, animal health and ecosystems. Regulatory clarity and flexibility, for biocidal, non-biocidal and innovative control approaches, would support this effort.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 33","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13498903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving public health laboratory preparedness at European Union level: learning points from experiences during the COVID-19 pandemic.","authors":"Sarah Parkinson, Saoirse Moriarty, Fifi Olumogba, Katarina Pisani, Daniela Moye Holz, Daniela Rodriguez Rincon, Cyril Barbezange, Eeva K Broberg","doi":"10.2807/1560-7917.ES.2026.31.32.2600017","DOIUrl":"10.2807/1560-7917.ES.2026.31.32.2600017","url":null,"abstract":"<p><p>This Perspective discusses how European Union (EU)-level action could support public health laboratories in preparing for future threats from respiratory infectious diseases. It draws extensively from a study that looked at the experience of public health laboratories in EU/ European Economic Area (EEA) countries during the COVID-19 pandemic. This study included a literature review and consultation with stakeholders from public health laboratories in EU/EEA countries and from EU institutions. We discuss how to address the challenges faced by public health laboratories during the COVID-19 pandemic, focusing particularly on the role of EU institutions. The Perspective concludes by discussing the importance of improving public health laboratory preparedness for future health threats when there is no ongoing public health emergency, instead of during a health emergency.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 32","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13476724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148764595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antibiotic treatment and antimicrobial resistance in urinary tract infections among the older population in Denmark, 1999 to 2023.","authors":"Majda Attauabi, Diana Schultz Christensen, Laura Marie Christensen, Jonas Kähler, Ute Wolff Sönksen, Anne Byriel Walls","doi":"10.2807/1560-7917.ES.2026.31.33.2500801","DOIUrl":"10.2807/1560-7917.ES.2026.31.33.2500801","url":null,"abstract":"<p><p>BACKGROUNDAntimicrobial resistance is highly correlated with inappropriate antimicrobial use. Urinary tract infections (UTIs) are the main infections treated with antibiotics in the population ≥ 70 years.AIMWe aimed to investigate antibiotic prescribing patterns for UTIs treatment among older people in Denmark and resistance trends to assess impact of antibiotic stewardship interventions and quality improvement strategies.METHODSThis national register-based surveillance study included people ≥ 70 years in Danish primary healthcare and assessed consumption of pivmecillinam, trimethoprim, nitrofurantoin and sulfamethizole from 1999 to 2023 and resistance levels from 2018 to 2023. Consumption data were obtained from the Register of Medicinal Product Statistics and resistance data from the Danish Microbiology Database. A review of quality improvement strategies from 2005 to 2020 was conducted to provide context for the study.RESULTSThe highest level of antibiotic consumption for UTIs in older people was in 2014 (447 prescriptions/1,000 people ≥ 70 years) and gradually decreased by 28.4% in 2023. Resistance to pivmecillinam, trimethoprim, sulfamethizole and nitrofurantoin in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> decreased significantly from 2018 to 2023, alongside the decline in antibiotic consumption. Focus on antibiotic stewardship was intensified after 2013, with several quality improvement initiatives and updated treatment guidelines aiming at improving diagnosis and antibiotic treatment.CONCLUSIONAntibiotic consumption for UTIs in people ≥ 70 years decreased notably, accompanied by a decrease in resistance levels, reflecting a positive impact of antibiotic stewardship programmes to improve diagnosis and treatment. However, a growing older population could place a strain on healthcare resources in the future.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 33","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13498900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}